• SENSEX 82,184.17
    -542.47 (--0.66%)
  • BANKNIFTY 57,066.05
    -144.40 (--0.25%)
  • Olectra Greentec
    1,590.00 1,786.65(%)
  • Kajaria Ceramics
    1,171.20 745.00(%)
  • Jayaswal Neco
    49.11 55.34(%)
  • Eternal Ltd
    314.40 314.40(%)
  • Force Motors
    20,563.00 20,563.00(%)
  • Kilburn Engg.
    546.50 546.50(%)
  • One 97
    1,128.00 1,128.00(%)
  • Tata Motors
    706.50 1,179.05(%)
  • Datamatics Glob.
    945.70 945.70(%)
  • Bombay Dyeing
    196.50 256.25(%)
  • Indian Energy Ex
    131.50 131.50(%)
  • Kotak Mah. Bank
    2,140.00 1,679.10(%)
  • Swiggy
    429.90 617.00(%)
  • Coforge
    1,670.70 1,120.01(%)
  • Canara Bank
    114.00 119.30(%)
  • Waaree Energies
    3,266.00 3,740.75(%)
  • Tilaknagar Inds.
    505.00 505.00(%)
  • Persistent Sys
    5,084.15 4,163.80(%)
  • Infosys
    1,548.20 1,307.10(%)
  • Ola Electric
    42.36 39.58(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Parmax Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 6620.0
  • ISIN : INE240T01014
39.49 0 (0.00%)
  • As on 25 Jul 2025 (EOD)

  • Today’s Low

    39.49

  • Today’s High

    40.28

  • Open

    40.28

  • Perv Close

    39.49

  • 52W Low

    31.50

  • 52W High

    55.02

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    14.77

  • Div & Yield %

    0.00

  • Book Value(₹)

    -7.21

  • Debt-Equity Ratio

    0.00

  • AGM Date

    24-Jul-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    14.77

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    3.74

  • BV (₹)

    -7.20

  • Sales( ₹ in Cr.)

    28.20

  • NP (in Cr.)

    -1.02

  • NP Var(%)

    82.0

  • Div%

    0.0

  • CPS (₹)

    0.00

  • EPS (₹)

    -2.70

  • Traded Value (₹ in Lakhs)

    14.77

  • 52 Week High

    55.02

  • 52 Week Low

    31.50

  • Price BSE

    39.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    14.77

  • P/C Ratio

    1,512.30

  • P/E Ratio

    -14.30

  • Price Vs.BV

    -2.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 11.05 15.42 18.25 26.20 20.93 12.01
Excise Duty 0.00 0.00 0.00 0.00 0.01 0.02
Net Sales 11.05 15.42 18.25 26.20 20.92 11.99
Other Income 0.05 0.04 0.06 0.09 0.10 0.05
Stock Adjustments -0.02 0.02 -0.43 0.52 -1.47 0.54
Total Income 11.08 15.48 17.88 26.81 19.55 12.58
EXPENDITURE :            
Raw Materials 7.03 5.51 6.29 13.96 9.79 5.74
Power and Fuel Cost 2.23 1.98 2.31 2.09 2.26 1.77
Employee Cost 2.91 2.80 3.46 3.54 2.91 2.08
Other Manufacturing Expenses 1.03 1.53 1.66 2.13 1.37 1.00
Selling and Administration Expenses 0.73 0.87 1.03 0.95 0.70 0.71
Miscellaneous Expenses 0.47 0.50 0.52 0.63 0.64 0.12
Employee Benefit Expenses 2.91 2.80 3.46 3.54 2.91 2.08
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 14.40 13.19 15.27 23.30 17.67 11.42
Operating Profit -3.32 2.29 2.63 3.52 1.87 1.16
Interest 0.62 0.37 0.39 0.37 0.13 0.03
Gross Profit -3.94 1.92 2.24 3.15 1.74 1.13
Depreciation 1.71 1.88 1.93 1.94 1.01 1.03
Profit Before Tax -5.65 0.04 0.31 1.21 0.73 0.10
Current Tax 0.12 0.19 0.22 0.30 0.15 0.08
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 -0.04 -0.05 0.16 0.15 -0.06
Reported Net Profit -5.78 -0.10 0.14 0.75 0.43 0.08
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -5.78 -0.10 0.14 0.75 0.43 0.08
Adjustment below Net Profit -0.01 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1.40 1.51 1.37 0.61 0.18 0.11
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -4.38 1.40 1.51 1.37 0.61 0.18
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -12.98 -0.23 0.32 1.69 0.96 0.18
Earnings Per Share(Adj)-Unit Curr -12.98 -0.23 0.32 1.69 - -
Book Value 0.16 13.16 13.39 13.07 11.38 10.41
Book Value(Adj)-Unit Curr 0.16 13.16 13.39 13.07 - -

Shareholding Pattern

  • Promoter Group

    30.80%

  • Public Share Holding

    69.20%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,152,450 30.80 1,152,450 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,152,450 30.80 1,152,450 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 3,600 0.10 2,000 3
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7,554 0.20 7,554 12
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 17,112 0.46 7,112 16
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,064,332 28.45 1,064,332 9
Individuals holding nominal share capital up to Rs. 1 lakh 1,296,251 34.65 348,621 2,332
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 200,000 5.35 200,000 1
Sub Total 2,588,850 69.20 1,629,620 2,374
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 3,741,300 100.00 2,782,070 2,377

Company Background

Parmax Pharma LtdPharmaceuticals - Indian - Bulk Drugs

  • Parmax Pharma Ltd
  • BSE Code : 6620.0
  • ISIN : INE240T01014

  • Incorporation Year

    1994

  • Registered Office

    Plot No 20 Survey No 52
    Tal Kotda Sangani Hadamtala, Rajkot,
    Gujarat-360311

  • Telephone

    91-2827-270534/535

  • FAX

  • Chairman

  • Managing Director

    Umang Alkesh Gosalia

  • Company Secretary

  • Auditor

    B A Shah S R Mehta & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Parmax Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Parmax Pharma 39.49 11.10 11.05 -7.05 0.00
Abbott India 34,635.25 6,684.73 6,409.15 52.03 44.95
Astrazeneca Phar 9,021.20 1,756.92 1,716.29 194.84 32.94
P & G Health Ltd 5,829.95 1,166.89 1,151.26 38.53 39.76
Glaxosmi. Pharma 3,159.95 3,866.05 3,723.49 58.25 58.72
Cipla 1,487.25 20,029.57 19,044.85 23.29 21.40
Amrutanjan Healt 700.40 437.58 421.23 39.84 20.84
Fermenta Biotec. 383.00 442.21 430.53 16.67 17.61
Guj. Themis Bio. 363.15 174.19 169.82 81.06 44.82
Bliss GVS Pharma 152.90 703.42 667.20 23.38 9.16
Ambalal Sarabhai 34.63 19.33 4.04 32.06 2.10